L&G Pharma Breakthrough UCITS ETF

IE00BF0H7608

Equities

The fund aims to replicate the performance of an index that invests in global companies involved in innovative and disruptive pharmaceutical technologies. It focuses on high-growth potential companies that are at the forefront of research and development of new treatments and medicines.

Back to search

Instruments

Price History

Asset Data

Manager

Legal & General Investment Management (LGIM)

Benchmark Index

Solactive Breakthrough Pharma Index

TER

0.49 %

Capitalization

74M

Capitalization Type

Acumulación

© 2025 ulcer.me . All rights reserved.

The information provided on this website is for informational and educational purposes only. It does not constitute financial, investment, or any other type of advice.